Executive Summary
Three civilian mega contracts totaling $512,134,848 in obligations were monitored for the period May 10, 2026 to May 10, 2026, with 0/3 defense-related and an average signal strength of 4.7/10. The highest materiality award is a $209.7M obligation to Nuclear Fuel Services Inc.
(BWX Technologies subsidiary) from DOE/NNSA for enriched uranium services, providing the sole bullish signal with $185.1M already outlayed over a 5-year period. The remaining awards—to Palmetto GBA, LLC ($181M from Railroad Retirement Board, historical and low outlay) and Signature Choice II, LLC ($121.4M from VA, future start and zero outlay)—are neutral, highlighting administrative services in health and claims processing. Dominant theme is civilian agency spending on nuclear/environmental and healthcare administration. Highest-conviction signal is bullish multi-year visibility for BWX Technologies. Key watch item: progress on option exercises across contracts, particularly BWX's path to $428.6M potential.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Mega Contracts Monitor ($100M+) digest from May 09, 2026.
Investment Signals (3)
- BWX Technologies Subsidiary Nuclear Fuel Services Secures $209.7M DOE/NNSA Uranium Contract (HIGH)▲
$209.7M firm fixed price obligation (base + options up to $428.6M) for enriched uranium conversion, with $185.1M outlayed since 2023-04-10 over 5-year performance to 2028-04-09. Non-competed award signals multi-year revenue visibility for BWX Technologies in civilian nuclear services.
- Palmetto GBA $181M RRB Contract Shows Stagnant $34.4M Outlay Post-2023 End Date (MEDIUM)▲
Only $34.4M outlayed on $181M obligation (up to $207.5M options) for Medicare admin services ended 2023-03-31, limiting ongoing visibility for this cost-plus award.
- Signature Choice II VA $121.4M Claims Processing Order at $0 Outlay (MEDIUM)▲
Firm fixed price delivery order for VA claims/customer service starts 2025-05-08 to 2026-11-07 with $121.4M obligation (up to $382M options) but zero funds outlayed to date.
Risk Flags (3)
- Execution [HIGH RISK]▼
High pricing risk on BWX Technologies' subsidiary Nuclear Fuel Services $209.7M firm fixed price DOE/NNSA contract, with $185.1M outlayed but options to $428.6M unexercised.
- Budget [HIGH RISK]▼
Palmetto GBA $181M Railroad Retirement Board contract ended 2023-03-31 with only $34.4M outlayed on cost-plus structure.
- Execution [MEDIUM RISK]▼
Signature Choice II $121.4M VA firm fixed price order has high pricing risk and $0 outlayed ahead of 2025-05-08 start.
Opportunities (3)
- ◆
BWX Technologies via Nuclear Fuel Services potential expansion from $209.7M obligation to $428.6M via DOE/NNSA options in enriched uranium services.
- ◆
Signature Choice II, LLC SDVOSB status supports $121.4M VA claims processing award with potential to $381.9M options.
- ◆
Palmetto GBA potential follow-on from $181M Railroad Retirement Board Medicare admin contract.
Sector Themes (2)
- ◆
Nuclear Fuel Services Inc. (BWX sub) $209.7M non-competed firm fixed price for uranium conversion/purification (NAICS 325180), with $185.1M outlayed.
- ◆
Palmetto GBA $181M RRB Medicare admin (ended 2023) and Signature Choice II $121.4M VA claims processing (starts 2025) reflect steady but low-outlay agency spend.
Watch List (3)
- 👁
{"entity"=>"BWX Technologies, Inc.", "reason"=>"$209.7M DOE/NNSA obligation to subsidiary with $185.1M outlayed; firm fixed price over 5 years.", "trigger"=>"option exercise to $428.6M; modifications to 2028-04-09 end date"}
- 👁
{"entity"=>"Palmetto GBA, LLC", "reason"=>"$181M RRB obligation with only $34.4M outlayed post-2023-03-31 end.", "trigger"=>"future outlays; contract extensions; follow-on awards"}
- 👁
{"entity"=>"Signature Choice II, LLC", "reason"=>"$121.4M VA SDVOSB award with $0 outlayed ahead of 18-month performance.", "trigger"=>"outlay progress; option exercises to $382M; 2026-11-07 performance"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 3 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Mega Contracts Monitor ($100M+)
🇺🇸 More from United States
View all →May 28, 2026
US Pre-Market SEC Filings Roundup — May 28, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals